Steffan Joe's Album: Wall Photos
Global digital
therapeutics market is growing at a CAGR of 19.7%, claims Roots Analysis
Report Keyword - Global, Digital, Therapeutics, Roots Analysis,
Report
Recent advances in information technology and
biomedical science have enabled the development of a number of versatile
digital solutions that are capable of either mimicking or augmenting, the
fundamental qualities of pharmacological interventions
Roots Analysis has announced the addition of “Digital Health Market:
Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of
Solution (Software Solution, Gaming Solution and Combination Solution), Type of
Therapy (Curative and Preventive), and Purpose of Solution (Medication
Replacement and Medication Augmentation” report to its list of offerings.
According to experts, digital therapeutic solutions are
primarily based on behavior modification and are designed to address a variety
of therapeutic needs across a wide range of disease indications. On the other
hand, several digital solutions have been developed to enable remote
doctor-patient consultations. Such solutions witnessed a surge in adoptions
amidst the COVID-19 pandemic.
To order this 500+ page report, which features 160+ figures
and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/digital-health-market/208.html
Key Market Insights
Nearly 230 digital therapeutic solutions are currently available
/ under development
Close to 45% of the aforementioned solutions are standalone
software applications targeting more than 60 unique indications.
Over 85% of digital therapeutic solutions are intended to
replace medication
Such solutions are currently available / being developed to
treat neurological disorders (27%), mental health problems (24%), and certain
metabolic disorders (24%). Alternatively, some digital health products are
designed to augment the effect of conventional therapeutics and are currently
being considered for treating substance use disorders and few mental health
problems.
220+ clinical trials, focused on digital therapeutics, have
been registered since 2004
Around 80,000 patients have been
enrolled in clinical research initiatives aimed to validate the efficacy of
digital therapeutics, and generate real world evidence concerning their
efficacy and safety. Close to 50% of such trials have been / are being
conducted in the US.
Nearly USD 1.9 billion invested by both private and public
investors in this domain
~85% of the total capital raised for digital
therapeutics-related initiatives was from venture capital investors, featuring
over 370 participants.
Partnership activity in this field has grown at a CAGR of
~42%, between 2015 and 2019
More than 70% of the reported deals were established after
2017, with the maximum activity being reported in 2019. Majority of the
instances captured in the report were focused on pilot product offering (29%)
and research and development agreements (21%).
North America and Europe are anticipated to capture over
70% of the market share by 2030
The market in Asia-Pacific
regions is anticipated to grow at a relatively faster pace (23.2%). In 2030,
digital solutions targeting metabolic disorders are likely to represent the
largest market share, in terms of revenues from product sales (26%), followed
by those intended for mental health problems (20%) and neurological disorders
(19%).
To request a sample copy / brochure of this report, please
visit this - https://www.rootsanalysis.com/reports/208/request-sample.html
Key Questions Answered
§ Who are the leading players engaged in the
development of digital therapeutic solutions?
§ What are the most popular therapeutic areas
addressed by digital health solutions?
§ What are the key factors influencing the price
of digital therapeutics?
§ What is the trend of capital investments in the
digital therapeutics market?
§ Which partnership models are commonly adopted
by stakeholders in this industry?
§ What type of marketing strategies are being
adopted by developers in this domain?
§ How is the COVID-19 pandemic likely to impact
the digital therapeutics market?
§ How is the current and future opportunity likely
to be distributed across key market segments?
§ What are the anticipated future trends related
to digital therapeutics?
The USD 8.86 billion (by 2030) financial opportunity within
the digital therapeutics market has been analyzed across the following
segments:
§ Type
of Solution
§
Standalone Software Application
§
Software Application + Device + Personal Coach
§
Software Application + Device + AI Support
§
Software Application + Device
§
Software Application + AI Support
§
Software Application + Personal Coach
§
Other Types of Solutions
§ Purpose
of Solution
§ Medication
Replacement
§ Medication
Augmentation
§ Type
of Therapy
§ Curative
§ Preventive
§ Business
Model
§ Business
to Consumer (Patients and Caregivers)
§ Business
to Business (Healthcare Providers, Payers, Employers and
Pharmaceutical Companies)
§ Therapeutic
Areas
§ Cardiovascular
Disorders
§ Chronic
Pain
§ Mental
Health Problems
§ Metabolic
Disorders
§ Neurological
Disorders
§ Respiratory
Disorders
§ Sleep
Disorders
§ Substance
Use Disorders
§ Others
§ Key
Geographical Regions
§ North
America
§ Europe
§ Asia-Pacific
§ Rest
of the world
The report features inputs from eminent industry
stakeholders, according to whom, digital therapeutic solutions are likely to
witness enhanced adoption due to their broader applicability, remote guidance
and other advanced features, thereby, offering lucrative opportunities to their
developers. The report includes detailed transcripts of the discussions held
with following industry experts:
§ Eran
Ofir (Co-Founder and Chief Executive Officer, Somatix)
§ Edouard
Gasser (Co-Founder and Chief Executive Officer, Tilak Healthcare)
§ Stephanie
Tilenius (Co-Founder and Chief Executive Officer, Vida Health)
§ Adam
Kaufman (Chief
Executive Officer, Canary
Health)
§ Vijay
Ravindran (Chief
Executive Officer, Floreo)
§ Palakh
R Sarogi (Vice President, Marketing, Wellthy Therapeutics),
Arani Sarkra (Senior Manager, Consumer Marketing, Wellthy Therapeutics) and
Yolande D’Mello (Marketing and Public Relations, Wellthy Therapeutics)
§ Amelie
Janson (Communication Manager, Voluntis)
§ Anonymous
(Founder and Chief Executive Officer, UK based Small-sized Company)
The research covers
brief profiles of key players engaged in the development of digital therapeutic
solutions; other popular industry players featured in the report include:
§
Akili Interactive
§
Beats Medical
§
Big Health
§
Bold Health
§
Click Therapeutics
§
CureApp
§
dreem
§
Ehave
§
Ginger
§
Happify Health
§
inMotion VR
§
Kaia Health
§
Lark Health
§
Mahana Therapeutics
§
MindMaze
§
Noom
§
NOVOSI
§
Omada Health
§
Palo Alto Health Sciences
§
Pear Therapeutics
§
Vida Health
§
Welldoc
§
ZOLL Medical
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/digital-health-market-focus-on-digital-therapeutic-monitoring-and-diag/208.html
You may also be interested in the following titles:
1.
AR / VR Based Healthcare Digital Marketing
Service Providers Market, 2020-2030
2. AI-Based Clinical Trial Solution Providers Market, 2020-2030
3.
Global Handheld Ultrasound Imaging Devices Market, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
therapeutics market is growing at a CAGR of 19.7%, claims Roots Analysis
Report Keyword - Global, Digital, Therapeutics, Roots Analysis,
Report
Recent advances in information technology and
biomedical science have enabled the development of a number of versatile
digital solutions that are capable of either mimicking or augmenting, the
fundamental qualities of pharmacological interventions
Roots Analysis has announced the addition of “Digital Health Market:
Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of
Solution (Software Solution, Gaming Solution and Combination Solution), Type of
Therapy (Curative and Preventive), and Purpose of Solution (Medication
Replacement and Medication Augmentation” report to its list of offerings.
According to experts, digital therapeutic solutions are
primarily based on behavior modification and are designed to address a variety
of therapeutic needs across a wide range of disease indications. On the other
hand, several digital solutions have been developed to enable remote
doctor-patient consultations. Such solutions witnessed a surge in adoptions
amidst the COVID-19 pandemic.
To order this 500+ page report, which features 160+ figures
and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/digital-health-market/208.html
Key Market Insights
Nearly 230 digital therapeutic solutions are currently available
/ under development
Close to 45% of the aforementioned solutions are standalone
software applications targeting more than 60 unique indications.
Over 85% of digital therapeutic solutions are intended to
replace medication
Such solutions are currently available / being developed to
treat neurological disorders (27%), mental health problems (24%), and certain
metabolic disorders (24%). Alternatively, some digital health products are
designed to augment the effect of conventional therapeutics and are currently
being considered for treating substance use disorders and few mental health
problems.
220+ clinical trials, focused on digital therapeutics, have
been registered since 2004
Around 80,000 patients have been
enrolled in clinical research initiatives aimed to validate the efficacy of
digital therapeutics, and generate real world evidence concerning their
efficacy and safety. Close to 50% of such trials have been / are being
conducted in the US.
Nearly USD 1.9 billion invested by both private and public
investors in this domain
~85% of the total capital raised for digital
therapeutics-related initiatives was from venture capital investors, featuring
over 370 participants.
Partnership activity in this field has grown at a CAGR of
~42%, between 2015 and 2019
More than 70% of the reported deals were established after
2017, with the maximum activity being reported in 2019. Majority of the
instances captured in the report were focused on pilot product offering (29%)
and research and development agreements (21%).
North America and Europe are anticipated to capture over
70% of the market share by 2030
The market in Asia-Pacific
regions is anticipated to grow at a relatively faster pace (23.2%). In 2030,
digital solutions targeting metabolic disorders are likely to represent the
largest market share, in terms of revenues from product sales (26%), followed
by those intended for mental health problems (20%) and neurological disorders
(19%).
To request a sample copy / brochure of this report, please
visit this - https://www.rootsanalysis.com/reports/208/request-sample.html
Key Questions Answered
§ Who are the leading players engaged in the
development of digital therapeutic solutions?
§ What are the most popular therapeutic areas
addressed by digital health solutions?
§ What are the key factors influencing the price
of digital therapeutics?
§ What is the trend of capital investments in the
digital therapeutics market?
§ Which partnership models are commonly adopted
by stakeholders in this industry?
§ What type of marketing strategies are being
adopted by developers in this domain?
§ How is the COVID-19 pandemic likely to impact
the digital therapeutics market?
§ How is the current and future opportunity likely
to be distributed across key market segments?
§ What are the anticipated future trends related
to digital therapeutics?
The USD 8.86 billion (by 2030) financial opportunity within
the digital therapeutics market has been analyzed across the following
segments:
§ Type
of Solution
§
Standalone Software Application
§
Software Application + Device + Personal Coach
§
Software Application + Device + AI Support
§
Software Application + Device
§
Software Application + AI Support
§
Software Application + Personal Coach
§
Other Types of Solutions
§ Purpose
of Solution
§ Medication
Replacement
§ Medication
Augmentation
§ Type
of Therapy
§ Curative
§ Preventive
§ Business
Model
§ Business
to Consumer (Patients and Caregivers)
§ Business
to Business (Healthcare Providers, Payers, Employers and
Pharmaceutical Companies)
§ Therapeutic
Areas
§ Cardiovascular
Disorders
§ Chronic
Pain
§ Mental
Health Problems
§ Metabolic
Disorders
§ Neurological
Disorders
§ Respiratory
Disorders
§ Sleep
Disorders
§ Substance
Use Disorders
§ Others
§ Key
Geographical Regions
§ North
America
§ Europe
§ Asia-Pacific
§ Rest
of the world
The report features inputs from eminent industry
stakeholders, according to whom, digital therapeutic solutions are likely to
witness enhanced adoption due to their broader applicability, remote guidance
and other advanced features, thereby, offering lucrative opportunities to their
developers. The report includes detailed transcripts of the discussions held
with following industry experts:
§ Eran
Ofir (Co-Founder and Chief Executive Officer, Somatix)
§ Edouard
Gasser (Co-Founder and Chief Executive Officer, Tilak Healthcare)
§ Stephanie
Tilenius (Co-Founder and Chief Executive Officer, Vida Health)
§ Adam
Kaufman (Chief
Executive Officer, Canary
Health)
§ Vijay
Ravindran (Chief
Executive Officer, Floreo)
§ Palakh
R Sarogi (Vice President, Marketing, Wellthy Therapeutics),
Arani Sarkra (Senior Manager, Consumer Marketing, Wellthy Therapeutics) and
Yolande D’Mello (Marketing and Public Relations, Wellthy Therapeutics)
§ Amelie
Janson (Communication Manager, Voluntis)
§ Anonymous
(Founder and Chief Executive Officer, UK based Small-sized Company)
The research covers
brief profiles of key players engaged in the development of digital therapeutic
solutions; other popular industry players featured in the report include:
§
Akili Interactive
§
Beats Medical
§
Big Health
§
Bold Health
§
Click Therapeutics
§
CureApp
§
dreem
§
Ehave
§
Ginger
§
Happify Health
§
inMotion VR
§
Kaia Health
§
Lark Health
§
Mahana Therapeutics
§
MindMaze
§
Noom
§
NOVOSI
§
Omada Health
§
Palo Alto Health Sciences
§
Pear Therapeutics
§
Vida Health
§
Welldoc
§
ZOLL Medical
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/digital-health-market-focus-on-digital-therapeutic-monitoring-and-diag/208.html
You may also be interested in the following titles:
1.
AR / VR Based Healthcare Digital Marketing
Service Providers Market, 2020-2030
2. AI-Based Clinical Trial Solution Providers Market, 2020-2030
3.
Global Handheld Ultrasound Imaging Devices Market, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis